Literature DB >> 1265620

Inhibition of cell-mediated immunity in patients with brain tumors.

H F Young, R Sakalas, A M Kaplan.   

Abstract

The immunocompetence of patients with glioblastomas, but not patients with astrocytomas, is altered. In vitro testing demonstrates an inhibitory factor in the serum of patients with glioblastomas which impairs lymphocytic responsiveness. The degree of this impairment appears important in relation to the clinical course.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1265620

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  21 in total

1.  Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma.

Authors:  F P Holladay; T Heitz-Turner; W L Bayer; G W Wood
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

2.  Detection of IgG on glioblastoma cell surface in vivo.

Authors:  K Tabuchi; W M Kirsch
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

Review 3.  The immunobiology of human gliomas.

Authors:  V Piguet; A C Diserens; S Carrel; J P Mach; N de Tribolet
Journal:  Springer Semin Immunopathol       Date:  1985

Review 4.  Neural and Pavlovian influences on immunity.

Authors:  R W Brittain; N I Wiener
Journal:  Pavlov J Biol Sci       Date:  1985 Oct-Dec

5.  Lymphocyte subsets in patients with brain tumors.

Authors:  M Uegaki; S Kobayashi; S Kuramoto; M M Yokoyama
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

6.  Cellular immunity and complement levels in hosts with brain tumours.

Authors:  M Matsutani; T Suzuki; T Hori; H Terao; K Takakura; K Nishioka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

7.  Chemosensitivity of malignant human brain tumors. Preliminary results.

Authors:  U Bogdahn
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

8.  Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.

Authors:  L H Elliott; W H Brooks; T L Roszman
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

9.  Depressed T lymphocyte function in brain tumor patients: monocytes as suppressor cells.

Authors:  G W Wood; R A Morantz
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

10.  Immunological monitoring of patients affected by anaplastic glioma concerning in effects of surgery, radio-, and chemotherapy. A preliminary report.

Authors:  F Servadei; R Parente; F Spagnolli; G Gaist; R Padovani; M Bucci; L Steiner
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.